Target Name: MIR1-1
NCBI ID: G406904
Review Report on MIR1-1 Target / Biomarker Content of Review Report on MIR1-1 Target / Biomarker
MIR1-1
Other Name(s): MicroRNA 1-1 | microRNA 1-1 | hsa-miR-1-5p | hsa-mir-1-1 | miRNA1-1 | mir-1-1 | hsa-miR-1-3p | MIRN1-1

MicroRNA 1-1 Regulates Various Cellular Processes

MicroRNA (miRNA) 1-1 (MIR1-1) is a non-coding RNA molecule that plays a crucial role in various biological processes. MIR1-1 is a key regulator of gene expression and has been implicated in a wide range of cellular processes , including cell growth, differentiation, and apoptosis.

MIR1-1 is composed of 20-22nt of DNA sequence that is usually expressed in the cytoplasm of eukaryotic cells. It is expressed in a variety of tissues and cells, including brain, heart, liver, and muscle. MIR1-1 has been shown to play a role in regulating gene expression and has been implicated in a wide range of cellular processes.

One of the most well-studied functions of MIR1-1 is its role in cell growth and differentiation. MIR1-1 has been shown to play a negative role in cell proliferation by inhibiting the activity of the oncogene transforming growth factor beta (TGF-β ). TGF-β is a critical regulator of cell growth and has been implicated in the development of many diseases, including cancer.

MIR1-1 has also been shown to play a role in cell apoptosis, which is the process by which cells die naturally in response to external stimuli, such as UV radiation, drug treatment, or cellular stress. MIR1-1 has also been shown to promote apoptosis by activating several apoptosis-related genes, including Bax. Bax is a pro-apoptosis gene that is involved in the regulation of cell life cycle and has been implicated in the development of many diseases, including cancer.

MIR1-1 has also been shown to play a role in the regulation of cellular signaling pathways. For example, MIR1-1 has been shown to inhibit the activity of the protein kinase A (PKA), which is involved in many cellular signaling pathways, including cell growth, differentiation, and apoptosis.

MIR1-1 has also been shown to play a role in the regulation of gene expression in the context of cellular stress. For example, MIR1-1 has been shown to increase the expression of genes involved in the regulation of cellular stress, such as the stress-responsive gene doublecortin (DCL), which is involved in the regulation of cellular stress responses.

MIR1-1 has also been shown to play a role in the regulation of cellular aging. For example, MIR1-1 has been shown to increase the expression of genes involved in the regulation of cellular aging, such as the gene telomere elastin (TLE) , which is involved in the regulation of telomere length and has been implicated in the development of many diseases, including cancer.

MIR1-1 has also been shown to play a role in the regulation of stem cell maintenance. For example, MIR1-1 has been shown to promote the self-renewal and survival of stem cells, which are important for the development and maintenance of tissues. and organs.

MIR1-1 has also been shown to play a role in the regulation of tissue repair. For example, MIR1-1 has been shown to promote the regulation of the DNA damage repair pathway, which is involved in the regulation of tissue repair after DNA damage.

MIR1-1 has also been shown to play a role in the regulation of neurodegenerative diseases. For example, MIR1-1 has been shown to promote the development of neurodegenerative diseases by suppressing the activity of genes involved in neuroprotection, such as the gene brain- derived neurotrophic factor (BDNF). BDNF is

Protein Name: MicroRNA 1-1

The "MIR1-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1-1HG | MIR1-2 | MIR100 | MIR100HG | MIR101-1 | MIR101-2 | MIR10394 | MIR10396B | MIR10399 | MIR103A1 | MIR103A2 | MIR103B1 | MIR103B2 | MIR105-1 | MIR105-2 | MIR10527 | MIR106A | MIR106B | MIR107 | MIR10A | MIR10B | MIR11181 | MIR11400 | MIR11401 | MIR1178 | MIR1179 | MIR1180 | MIR1181 | MIR1182 | MIR1183 | MIR1184-1 | MIR1184-2 | MIR1184-3 | MIR1185-1 | MIR1185-2 | MIR1193 | MIR1197 | MIR1199 | MIR1200 | MIR1202 | MIR1203 | MIR1204 | MIR1205 | MIR1206 | MIR1207 | MIR1208 | MIR12129 | MIR12135 | MIR12136 | MIR122 | MIR1224 | MIR1225 | MIR1226 | MIR1227 | MIR1228 | MIR1229 | MIR1231 | MIR1233-1 | MIR1233-2 | MIR1234 | MIR1236 | MIR1237 | MIR1238 | MIR124-1 | MIR124-1HG | MIR124-2 | MIR124-2HG | MIR124-3 | MIR1243 | MIR1244-1 | MIR1244-2 | MIR1244-3 | MIR1245A | MIR1245B | MIR1246 | MIR1247 | MIR1248 | MIR1249 | MIR1250 | MIR1251 | MIR1252 | MIR1253 | MIR1254 | MIR1255A | MIR1255B1 | MIR1255B2 | MIR1256 | MIR1257 | MIR1258 | MIR125A | MIR125B1 | MIR125B2 | MIR126 | MIR1260A | MIR1260B | MIR1261 | MIR1262 | MIR1263 | MIR1264 | MIR1265